Related Experiment Video
Updated: Sep 17, 2025

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain
Published on: October 24, 2017
Small-diffusible aggregates, plaques, tangles, and dynamic equilibria: Untangling Alzheimer's disease
Emre Fertan1,2, Georg Meisl1,2, David Klenerman1,2
1Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Introduction:
Beta-amyloid plaques and hyperphosphorylated tau tangles are the neuropathological hallmarks of Alzheimer's disease; however, their relevance in the pathophysiology is not fully understood. It has been suggested that these larger and insoluble aggregates may not be the most toxic forms of beta-amyloid and tau in Alzheimer's disease, and the disease progression may actually be promoted by the small-diffusible aggregates.
Methods And Results:
We combine the recent findings from our group and other key research to put forward the hypotheses that the formation of the small-diffusible aggregates of beta-amyloid and tau and their larger insoluble counterparts is not a linear process.
Discussion:
While the small-diffusible aggregate formation of beta-amyloid and tau is a passive process, regulated by thermodynamic equilibria, the formation of large-insoluble aggregates is an active process, regulated by microglia and neurons, which to an extent is a protective mechanism against the toxicity of the smaller aggregates.
Highlights:
Plaques and tangles may be made by active processes in Alzheimer's disease. The small-soluble aggregates may be the more toxic species in Alzheimer's disease. Pathology may be caused by the imbalance of production and clearance of aggregates. Plaques and tangle formation may be attempts to restore the homeostatic equilibrium.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....

